HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 01-25-2006, 01:34 PM   #1
LANI
Guest
 
Posts: n/a
Blood Markers To Detect Bone Mets Earlier--will They Become Adopted?

The current dogma is waiting until complaints of bony pain or tenderness occur.

ABSTRACT: The Relative Use of Eight Collagenous and Noncollagenous Markers for Diagnosis of Skeletal Metastases in Breast, Prostate, or Lung Cancer Patients [Cancer Epidemiology, Biomarkers and Prevention; Subscribe]
The present study was sought to assess the relative use of eight biomarkers for the detection of bone metastases in cancer forms frequently spreading to the skeleton. Participants were 161 patients with either breast, prostate, or lung cancer. The presence and extent of bone metastases was assessed by imaging techniques (computer tomography and/or magnetic resonance imaging) and Technetium-99m scintigraphy. Serum or urinary level of the bone resorption markers (??CTX, ??CTX, NTX, and ICTP), formation marker (BSAP), and osteoclastogenesis markers (osteoprotegerin, RANKL, and TRAP5b) was measured by commercially available immunoassays. When assessed on a group basis, all biomarkers, except for osteoprotegerin and RANKL, were significantly elevated in patients compared with those without bone metastases (P < 0.05). Biomarkers had greater diagnostic value in breast and prostate cancer patients, yet ??CTX, NTx, and ICTP were able to discriminate lung cancer patients with or without bone metastases (P < 0.05). Strong linear associations were seen between the extent of skeletal infiltration and levels of the different biomarkers, except for osteoprotegerin and RANKL. Furthermore, all biomarkers (except for osteoprotegerin and RANKL) were indicative at the early stage of skeletal involvement (one to five metastases). When expressing sensitivity as the percentage increase in biomarker level relative to patients without bone metastases, ??CTX showed the largest relative increases at each stage of the metastatic disease. These results suggest that closer monitoring of cancer patients with serial measures of biomarkers might facilitate the timely diagnosis of skeletal metastases.
  Reply With Quote
Old 01-28-2006, 07:06 AM   #2
HavahJ
Senior Member
 
Join Date: Dec 2005
Posts: 98
Discovery of bone mets

My marker went up a little so we did a pet scan and found bone mets to top of spine. I'm certainly glad we found it early before I could get symptoms!
HavahJ is offline   Reply With Quote
Old 01-28-2006, 09:37 AM   #3
Barbara
Senior Member
 
Join Date: Oct 2005
Location: Payson, Arizona
Posts: 96
Markers

HavahJ:


Did you have these new markers run for bone mets or was it your CA 27-29 that went up?

Barbara
Barbara is offline   Reply With Quote
Old 01-28-2006, 11:34 AM   #4
HavahJ
Senior Member
 
Join Date: Dec 2005
Posts: 98
It was my Ca 27,29. It went 13, 17, 25, 36.
HavahJ is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 07:47 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter